It works by reducing stomach acid and is commonly used to relieve indigestion, heartburn, and treat gastroesophageal reflux disease (GERD) and ulcers of the stomach and intestines.
Ranitidine is sold over the counter under popular brand names such as Rantac, Zinetac, and Aciloc.
While India has thus far refrained from banning ranitidine, it was removed from the National List of Essential Medicines (NLEM) in 2022, and multiple safety advisories were issued.
The story "Is your heartburn pill safe? Panel recommends banning ranitidine in India" has 440 words across 21 sentences, which will take approximately 2 - 4 minutes for the average person to read.
Which news outlet covered this story?
The story "Is your heartburn pill safe? Panel recommends banning ranitidine in India" was covered 12 hours ago by Business Standard, a news publisher based in India.
How trustworthy is 'Business Standard' news outlet?
Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news.
The outlet is headquartered in India and publishes an average of 229 news stories per day.
It's most recent story was published 3 hours ago.
What do people currently think of this news story?
The sentiment for this story is currently Negative, indicating that people regard this as "bad news".
How do I report this news for inaccuracy?
You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.